People: Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

99.88USD
2:00pm EDT
Change (% chg)

$0.15 (+0.15%)
Prev Close
$99.73
Open
$99.60
Day's High
$99.99
Day's Low
$99.38
Volume
770,037
Avg. Vol
2,403,570
52-wk High
$109.49
52-wk Low
$95.10

Search Stocks

Coleman, Mary Sue 

Dr. Mary Sue Coleman, Ph.D. is an Independent Director of Johnson And Johnson. She joined the Board of Directors in 2003 and is a member of the Audit Committee and the Science, Technology & Sustainability Committee. She is President Emerita of the University of Michigan, having served as President from August 2002 to July 2014. She also was a Professor of Biological Chemistry in the University of Michigan Medical School and a Professor of Chemistry in the University of Michigan College of Literature, Science and the Arts. From 1995 to July 2002, Dr. Coleman served as President of the University of Iowa. Prior to 1995, Dr. Coleman served as Provost and Vice President for Academic Affairs at the University of New Mexico, Vice Chancellor for Graduate Studies & Research and Associate Provost and Dean of Research at the University of North Carolina at Chapel Hill, and a member of the biochemistry faculty and an administrator at the Cancer Center of the University of Kentucky in Lexington. Elected to the National Academy of Sciences’ Institute of Medicine in 1997, Dr. Coleman is a Fellow of the American Academy of Arts and Sciences and the American Association for the Advancement of Science. Dr. Coleman is a Trustee of the Gerald R. Ford Foundation, the Gates Cambridge Scholarship program, and the Mayo Clinic Foundation, and is on the Board of Directors of The Kavli Foundation.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Alex Gorsky

24,989,300

Dominic Caruso

10,349,000

Sandra Peterson

7,086,610

Paulus Stoffels

18,339,300

Michael Ullmann

5,960,690

Peter Fasolo

3,621,280
As Of  27 Dec 2014
Search Stocks